Developer docs
API playgroundTry for free, no card

Search company profiles

Microbial Insights

Full company profile

uuid000lzmh

Namestring
Microbial Insights
Websiteurl
microbe.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Microbial Insights is a privately held, for-profit company headquartered in Knoxville, Tennessee, founded in 1992. Per the firm's own positioning, it is engaged in "the development and application of cutting edge molecular biological tools," indicating a focus on building and deploying nucleic-acid-based or other molecular-level analytical methods. The company operates with a small team of 11-50 employees and maintains a web presence at microbe.com, signaling it is an active operating business with laboratory or applied science capabilities rather than a dormant entity.

The company's product surface, technology stack, and pricing structure are not disclosed in the available input data — the company detail pages returned only loading/verification placeholders. As a result, it is not possible to characterize with precision the underlying platform architecture, the specific molecular techniques deployed (e.g., PCR/qPCR, 16S sequencing, metagenomics, qPCR microbial source tracking), the laboratory throughput model, or the cadence of product releases. The firm is best understood as a small, specialized life-sciences operator serving a niche requiring microbiological or molecular biological analysis; whether its primary revenue comes from fee-for-service testing, licensed kits/reagents, or contract research cannot be determined from the supplied sources.

Commercially, the company has not disclosed funding history, customer counts, pricing, partnerships, awards, patents, leadership team, M&A activity, or geographic footprint in the available data. This absence is itself an analytical signal: the lack of publicly visible commercial activity suggests Microbial Insights is a sub-scale, privately held, likely services-oriented laboratory rather than a venture-backed or acquirer-stage growth company. Any deeper inference about go-to-market, customer mix, or revenue mechanics would require primary-source confirmation.

Short descriptiontext

Microbial Insights is a privately held Knoxville, Tennessee-based life-sciences company, founded in 1992, that develops and applies molecular biological tools. With 11-50 employees, it serves customers requiring specialized microbiological and molecular analysis.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKnoxville, United States
HQ citystring
Knoxville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
microbial analysis services, molecular biology testing, DNA-based diagnostics, qPCR testing services, environmental microbiology
Industry3 codes
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Microbial Analysis Laboratory Services
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Microbial Insights is engaged in the development and application of cutting-edge molecular biological tools. The company leverages molecular biology techniques to deliver microbial analysis and identification services to clients requiring detailed characterization of microbial communities. Operations are based in Knoxville, United States, and the firm has been operating in this field since 1992.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Molecular Microbial Analysis Services
CategoryMicrobial Analysis Laboratory Services
No data
Peers10 records
1Diversigen
TypeDirect peer
Description

Diversigen provides end-to-end microbiome and metagenomics sequencing and bioinformatics services for academic, agricultural, and industrial clients — directly comparable to Microbial Insights' molecular biology service offering. Now part of Eurofins, it represents the scaled version of the same specialty lab model.

TypeDirect peer
Description

CosmosID offers microbial identification and microbiome analytics services using proprietary NGS-based platforms, directly competing with Microbial Insights in the molecular biology tools and microbiome services space. Both serve industrial, environmental, and research customers with similar assay offerings.

TypeDirect peer
Description

Zymo Research manufactures molecular biology tools, nucleic acid purification kits, and provides microbiome services — overlapping with Microbial Insights' "molecular biological tools" positioning across both products and services.

TypeDirect peer
Description

MR DNA offers next-generation sequencing and molecular biology services for microbiome, environmental, and agricultural customers. Comparable in scale and service mix to Microbial Insights, with similar focus on molecular-based microbial characterization.

TypeDirect peer
Description

RTL Genomics provides NGS-based microbial sequencing and bioinformatics services for environmental, agricultural, and clinical research customers, operating in the same specialty molecular biology services category as Microbial Insights.

TypeBroad incumbent
Description

Eurofins is a global lab services conglomerate offering molecular biology, microbiome, and environmental testing at scale. As a broad incumbent, it offers overlapping capabilities but as part of a much wider portfolio, and does not specialize in Microbial Insights' niche.

TypeBroad incumbent
Description

Charles River provides life science research services including microbial and molecular biology offerings. Comparable as a broad CRO/lab services incumbent with overlapping microbiological capabilities, though its portfolio spans well beyond Microbial Insights' specialty.

8IDbyDNA
TypeEmerging player
Description

IDbyDNA develops metagenomics-based infectious disease and microbiome analysis platforms with both clinical and research applications. Comparable as a molecular biology and microbial analytics provider, though focused more on clinical metagenomics than Microbial Insights' environmental/industrial orientation.

9Second Genome
TypeEmerging player
Description

Second Genome uses microbiome science and molecular tools for therapeutic discovery. Partially comparable — overlaps in microbiome molecular biology and analytics capabilities but focused on pharma rather than the environmental/industrial mix Microbial Insights serves.

TypeDirect peer
Description

Source Molecular provides DNA-based microbial source tracking and molecular biology testing services for environmental and water quality applications, directly comparable to Microbial Insights' molecular biology tools and environmental microbiology focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Microbial Insights

Microbial Analysis Laboratory Servicesmicrobe.com

Microbial Insights is a privately held Knoxville, Tennessee-based life-sciences company, founded in 1992, that develops and applies molecular biological tools. With 11-50 employees, it serves customers requiring specialized microbiological and molecular analysis.

What Microbial Insights does

Microbial Insights is a privately held, for-profit company headquartered in Knoxville, Tennessee, founded in 1992. Per the firm's own positioning, it is engaged in "the development and application of cutting edge molecular biological tools," indicating a focus on building and deploying nucleic-acid-based or other molecular-level analytical methods. The company operates with a small team of 11-50 employees and maintains a web presence at microbe.com, signaling it is an active operating business with laboratory or applied science capabilities rather than a dormant entity.

The company's product surface, technology stack, and pricing structure are not disclosed in the available input data — the company detail pages returned only loading/verification placeholders. As a result, it is not possible to characterize with precision the underlying platform architecture, the specific molecular techniques deployed (e.g., PCR/qPCR, 16S sequencing, metagenomics, qPCR microbial source tracking), the laboratory throughput model, or the cadence of product releases. The firm is best understood as a small, specialized life-sciences operator serving a niche requiring microbiological or molecular biological analysis; whether its primary revenue comes from fee-for-service testing, licensed kits/reagents, or contract research cannot be determined from the supplied sources.

Commercially, the company has not disclosed funding history, customer counts, pricing, partnerships, awards, patents, leadership team, M&A activity, or geographic footprint in the available data. This absence is itself an analytical signal: the lack of publicly visible commercial activity suggests Microbial Insights is a sub-scale, privately held, likely services-oriented laboratory rather than a venture-backed or acquirer-stage growth company. Any deeper inference about go-to-market, customer mix, or revenue mechanics would require primary-source confirmation.

Microbial Insights firmographics

Firmographics
Name
Microbial Insights
Website
https://microbe.com
Company type
Private
Founded year
1992
Headcount range
11–50 employees
Short description
Microbial Insights is a privately held Knoxville, Tennessee-based life-sciences company, founded in 1992, that develops and applies molecular biological tools. With 11-50 employees, it serves customers requiring specialized microbiological and molecular analysis.
Ownership category
akta.pro rank

Microbial Insights industry classification

Industry
Product category
Microbial Analysis Laboratory Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Microbial analysis services
  • Molecular biology testing
  • DNA-based diagnostics
  • QPCR testing services
  • Environmental microbiology

Where Microbial Insights is headquartered

Location

Headquarters

HQ city
Knoxville
HQ country
United States
HQ region
North America

Markets served

Microbial Insights business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Microbial Insights product offering

Product offering

Core offering

Microbial Insights is engaged in the development and application of cutting-edge molecular biological tools. The company leverages molecular biology techniques to deliver microbial analysis and identification services to clients requiring detailed characterization of microbial communities. Operations are based in Knoxville, United States, and the firm has been operating in this field since 1992.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Microbial Analysis Services

Companies that use Microbial Insights

Customer profile

Ideal customer profiles1 record

Microbial Insights technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Microbial Insights competitors and assessment

Company assessment

Direct peers

  • Diversigen: Diversigen provides end-to-end microbiome and metagenomics sequencing and bioinformatics services for academic, agricultural, and industrial clients — directly comparable to Microbial Insights' molecular biology service offering. Now part of Eurofins, it represents the scaled version of the same specialty lab model.
  • CosmosID: CosmosID offers microbial identification and microbiome analytics services using proprietary NGS-based platforms, directly competing with Microbial Insights in the molecular biology tools and microbiome services space. Both serve industrial, environmental, and research customers with similar assay offerings.
  • Zymo Research: Zymo Research manufactures molecular biology tools, nucleic acid purification kits, and provides microbiome services — overlapping with Microbial Insights' "molecular biological tools" positioning across both products and services.
  • MR DNA (Molecular Research LP): MR DNA offers next-generation sequencing and molecular biology services for microbiome, environmental, and agricultural customers. Comparable in scale and service mix to Microbial Insights, with similar focus on molecular-based microbial characterization.
  • RTL Genomics: RTL Genomics provides NGS-based microbial sequencing and bioinformatics services for environmental, agricultural, and clinical research customers, operating in the same specialty molecular biology services category as Microbial Insights.
  • Source Molecular Corporation: Source Molecular provides DNA-based microbial source tracking and molecular biology testing services for environmental and water quality applications, directly comparable to Microbial Insights' molecular biology tools and environmental microbiology focus.

Broad incumbents

  • Eurofins Scientific: Eurofins is a global lab services conglomerate offering molecular biology, microbiome, and environmental testing at scale. As a broad incumbent, it offers overlapping capabilities but as part of a much wider portfolio, and does not specialize in Microbial Insights' niche.
  • Charles River Laboratories: Charles River provides life science research services including microbial and molecular biology offerings. Comparable as a broad CRO/lab services incumbent with overlapping microbiological capabilities, though its portfolio spans well beyond Microbial Insights' specialty.

Emerging players

  • IDbyDNA: IDbyDNA develops metagenomics-based infectious disease and microbiome analysis platforms with both clinical and research applications. Comparable as a molecular biology and microbial analytics provider, though focused more on clinical metagenomics than Microbial Insights' environmental/industrial orientation.
  • Second Genome: Second Genome uses microbiome science and molecular tools for therapeutic discovery. Partially comparable — overlaps in microbiome molecular biology and analytics capabilities but focused on pharma rather than the environmental/industrial mix Microbial Insights serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Microbial Insights social profiles

Digital presence

Microbial Insights financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Microbial Insights leadership team

Management profile

Number of profiles

Microbial Insights funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Microbial Insights M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microbial Insights

What does Microbial Insights do?

Microbial Insights is engaged in the development and application of cutting-edge molecular biological tools. The company leverages molecular biology techniques to deliver microbial analysis and identification services to clients requiring detailed characterization of microbial communities. Operations are based in Knoxville, United States, and the firm has been operating in this field since 1992.

When was Microbial Insights founded?

Microbial Insights was founded in 1992. It employs 11 to 50 people.

Where is Microbial Insights based?

Microbial Insights is headquartered in Knoxville, United States, in the North America region.

Who are Microbial Insights's main competitors?

Direct peers on record are Diversigen, CosmosID, Zymo Research, MR DNA (Molecular Research LP), RTL Genomics and Source Molecular Corporation. Broad incumbents are Eurofins Scientific and Charles River Laboratories. Emerging players are IDbyDNA and Second Genome.

Does Microbial Insights have an API?

No public API is recorded for Microbial Insights.

What industry is Microbial Insights in?

Microbial Insights's product category is Microbial Analysis Laboratory Services. Its primary akta.pro industry code is HLAGANAH, Microbiome & Metagenomics Services, with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MicrobeAddressing the Challenges of the Midstream Oil and Gas SectorA promotional article outlines midstream oil and gas challenges, citing that over 62% of domestic pipelines are more than 21 years old, corrosion-related maintenance can raise output by 25% and cut costs by 30%, and 1% unplanned downtime can cost over $5 million annually. It promotes Microbial Insights' molecular microbiological methods, including QuantArray-MIC and next-generation sequencing, for detecting microbiologically influenced corrosion.NewswireDora Taggart, CEO of Microbial Insights, Wins the Prestigious NGWA Technology AwardDora Taggart, CEO of Microbial Insights, won the 2022 NGWA Technology Award, presented during Groundwater Week in Las Vegas. The award recognizes her contributions to groundwater microbiology and remediation tools. The company has offered microbial diagnostic solutions for over three decades.WileyLessons learned from 20 years of molecular biological tools in petroleum hydrocarbon remediationThe article reviews the evolution and application of molecular biological tools (MBTs) such as qPCR, NGS, and stable isotope probing over the past two decades to enhance the cost-effectiveness of petroleum hydrocarbon remediation. It highlights how these technologies provide critical data on microbial activity and biodegradation potential, enabling better selection of treatment strategies like in situ chemical oxidation or monitored natural attenuation. The text cites Microbial Insights, Inc. as a primary example, noting it processed over 116,000 groundwater samples from nearly 20,000 projects in the United States between 2001 and 2021.